Donate to Hurricane Recovery

Medicaid Bulletin

SPECIAL BULLETIN: NC Medicaid Temporary Flexibilities due to Hurricane Dorian

Thursday, September 5, 2019

*NOTE: THE CONTENT OF THIS BULLETIN HAS BEEN UPDATED. REFER TO THE SEPT. 24, 2019 MEDICAID SPECIAL BULLETIN FOR REVISED FLEXIBILITIES.

This Special Bulletin includes several articles regarding Hurricane Dorian.

SPECIAL BULLETIN: Review of Current Issues with Searching the Enrollment Broker Provider Directory

Wednesday, September 4, 2019

As of the end of August 2019, several issues have been identified with the search function in the Enrollment Broker Provider Directory, including duplicate results, and difficulty finding doctors based on specific criteria such as gender or name.

Procedure for 340B Drug Claim Submissions

Tuesday, September 3, 2019

The North Carolina Division of Health Benefits (DHB) would like to reiterate the 340B provider and claim submission requirements for both the outpatient pharmacy and Physician’s Drug Program (PDP). 

Revisions to Hematopoietic Stem Cell Transplantation Clinical Coverage Policies

Tuesday, September 3, 2019

Hematopoietic Stem Cell Transplantation (HSCT) clinical coverage policies have been revised. The revisions, which will become effective Oct. 1, 2019 are outlined below:

Updates to NC Medicaid Electronic Health Record (EHR) Incentive Program

Tuesday, September 3, 2019

The NC Medicaid EHR Incentive Payment System (NC-MIPS) is only accepting Program Year 2019 Stage 3 Meaningful Use (MU) attestations. All eligible professionals (EPs) attesting in Program Year 2019 will be required to attest to Stage 3 MU and use a 2015 Edition of certified EHR technology (CEHRT).

SPECIAL BULLETIN: Extension of Open Enrollment and Launching Statewide in One Phase

Tuesday, September 3, 2019

The Department of Health and Human Services (DHHS) will extend open enrollment for Medicaid beneficiaries and move to a statewide transition to managed care on Feb. 1, 2020.

Dexamethasone ophthalmic insert 0.4 mg, for intracanalicular use (Dextenza®) HCPCS code J3490: Billing Guidelines

Tuesday, September 3, 2019

Effective with date of service June 20, 2019, the North Carolina Medicaid and NC Health Choice programs cover dexamethasone ophthalmic insert 0.4 mg, for intracanalicular use (Dextenza) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J3490 - Unclassified drugs.

Recent Changes to State Health Information Exchange, NC HealthConnex

Tuesday, September 3, 2019

North Carolina’s state-designated health information exchange, NC HealthConnex, was created in 2015 by the North Carolina General Assembly to help bridge the gap between distinct electronic health record systems and health care networks to support whole patient care. With over seven million unique patient records and growing, NC HealthConnex is working to connect the state’s health care providers to deliver a holistic view of a patient’s record.

Polatuzumab vedotin-piiq for Injection, for Intravenous Use (Polivy™) HCPCS code J9999: Billing Guidelines

Tuesday, September 3, 2019

Effective with date of service June 11, 2019, the North Carolina Medicaid and NC Health Choice programs cover polatuzumab vedotin-piiq for injection, for intravenous use (Polivy) for use in the Physician Administered Drug Program (PADP) when billed with HCPCS code J9999 - Not otherwise classified, antineoplastic drugs.

Influenza Vaccine and Reimbursement Guidelines for 2019-2020 for North Carolina Medicaid and NC Health Choice

Tuesday, September 3, 2019

A fully detailed outline of the influenza vaccine and reimbursement guidelines for 2019-2020 for North Carolina Medicaid and NC Health Choice was distributed in a Medicaid Special Bulletin on Aug. 27, 2019.

Subscribe to Medicaid Bulletins Updates

Medicaid Bulletin Monthly Digest

Medicaid Bulletin Archive (Prior to January 2018)

Articles beginning January 2018 are available in the blog format below.

Associated Files